No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Obicetrapib Reduced LDL Cholesterol in Patients at High Cardiovascular Risk

byJinny TsangandAlisha Yi

July 15, 2025

in StudyGraphics

Reading Time: 1 min read

Click here to read this study in NEJM.

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc.Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

An elevated Apolipoprotein B to Apolipoprotein A ratio may be associated with increased kidney stone recurrence

2 Minute Medicine Rewind

The preoperative combination of evolocumab and rosuvastatin may not reduce major adverse cardiovascular events

Tags: apolipoprotein B (apoB)atherosclerotic cardiovascular disease (ASCVD)cardiology cardiovascular risk efficacy LDL cholesterol Obicetrapib rct safety

St. Louis hospital-based violence intervention program did not significantly affect reinjury outcomes

RelatedReports

Contrast-enhanced computed tomography associated with high sensitivity to renal stone detection

Chronic Disease

An elevated Apolipoprotein B to Apolipoprotein A ratio may be associated with increased kidney stone recurrence

January 13, 2026

Remote patient monitoring did not reduce heart failure readmissions: The BEAT-HF trial

Weekly Rewinds

2 Minute Medicine Rewind

January 13, 2026

Using HEART score to risk stratify patients with chest pain is safe but underutilized in the ED

Cardiology

The preoperative combination of evolocumab and rosuvastatin may not reduce major adverse cardiovascular events

January 12, 2026

Cardiology

Late ventricular fibrillation following myocardial infarction is associated with increased risk of 1-year mortality

January 12, 2026

Intensive rehabilitation not superior to traditional therapy for arm function after stroke

Thrombolysis-to-puncture time greater than 70 minutes decreases odds of successful thrombectomy

#VisualAbstract: Insulin Efsitora is Noninferior to Insulin Glargine in Type 2 Diabetes without Previous Insulin Therapy

New-generation antiseizure medications are better tolerated for patients with epilepsy

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result